Back
MercadoLibre Vs. Akero Therapeutics Industry Stock Comparison
Buy
53
MELI
MercadoLibre
Last Price:
$1,946.25
Seasonality Move:
14.78%
Buy
59
AKRO
Akero Therapeutics
Last Price:
$55.30
Seasonality Move:
-13.54%
Buy
53
MercadoLibre (MELI)
is a Buy
Is MercadoLibre a Buy, Sell or Hold?
-
The current MercadoLibre [MELI] share price is $1,947.32. The Score for MELI is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
MELI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $55.36. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MELI Stock Price Chart
What is MercadoLibre's stock price today?
-
The MercadoLibre share price today is $1,947.32Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MELI is experiencing slight buying pressure.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $55.36Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
MELI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 20.07 | Buy |
Relative Strength Index (14 RSI): | 66.06 | Buy |
Chaikin Money Flow: | 38456 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1734.65 - 1859.75) | Buy |
Bollinger Bands (100): | (1816.25 - 2075.19) | Buy |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.46 | Buy |
Relative Strength Index (14 RSI): | 86.44 | Buy |
Chaikin Money Flow: | -1207308 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (20.44 - 40.6) | Buy |
Bollinger Bands (100): | (24.53 - 35.29) | Buy |
MELI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1862.97 | Buy |
20-day SMA: | 1813.84 | Buy |
50-day SMA: | 1852.26 | Buy |
200-day SMA: | 1817.85 | Buy |
8-day EMA: | 1873.35 | Buy |
20-day EMA: | 1837.04 | Buy |
50-day EMA: | 1853.78 | Buy |
200-day EMA: | 1812.16 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.44 | Buy |
20-day SMA: | 31.04 | Buy |
50-day SMA: | 30.48 | Buy |
200-day SMA: | 26.55 | Buy |
8-day EMA: | 43.24 | Buy |
20-day EMA: | 35.07 | Buy |
50-day EMA: | 31.47 | Buy |
200-day EMA: | 28.51 | Buy |
MercadoLibre Earnings Growth & MELI Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $10.30 per share, and an increase next year of $18.40 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $0.02 per share.
MercadoLibre Technical Analysis
Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
16 | 17 | 21 | 22 | 23 | 24 | 27 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |